Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether using Taclonex ointment under a hydrogel
patch is more effective than using the ointment alone in treating psoriasis. Taclonex
ointment is currently FDA approved for use on psoriasis. The hydrogel patch is a type of
adhesive pad and contains no medications. It is currently FDA approved and has been shown to
be safe and virtually free of side effects. The hypothesis is that psoriatic plaques which
are treated with Taclonex ointment under a hydrogel patch will be more effectively treated
compared to psoriatic plaques treated with Taclonex alone.